C.B.D.

C.B.D. is a hybrid cannabis strain with up to 6.0% THC, known for its focused effects and earthy and floral flavor profile.

C.B.D. is a cannabis strain specifically bred for its high cannabidiol (CBD) content and low tetrahydrocannabinol (THC) levels, making it one of the pioneering medical cannabis varieties. The strain emerged in the early 2010s as breeders responded to growing interest in non-intoxicating cannabis options, with multiple seed companies developing their own versions. While the exact genetic origins vary between breeders, most C.B.D. strains are derived from crossing high-CBD hemp varieties with traditional cannabis strains to create plants that maintain desirable terpene profiles while minimizing psychoactive effects.

The plant typically displays a balanced hybrid structure with medium height and dense, resinous buds. The appearance varies depending on the specific phenotype, but commonly features light green to olive-colored flowers with orange pistils and a generous coating of trichomes. The leaves often show slight indica influence with broader blades, though sativa-leaning phenotypes also exist. The strain's most notable feature is its cannabinoid ratio, which typically ranges from 15:1 to 30:1 CBD to THC, though some phenotypes can reach even higher CBD concentrations.

C.B.D. represents a significant development in cannabis breeding, marking a shift toward therapeutic applications without strong psychoactive effects. The strain has become foundational for numerous CBD-dominant hybrids that followed and has been used extensively in medical cannabis programs worldwide. Its development coincided with increased scientific interest in CBD's potential therapeutic properties, though users should note that individual phenotypes can vary significantly in their exact cannabinoid and terpene profiles.